We offer an extensive range of assays in human genitourinary tissues including uterus, bladder, prostate, ureter and urethra. Our scientists can estimate the therapeutic efficacy of potential new therapies or assess the likelihood of off-target effects in these tissues.
Diagram of the organ bath model used for our Genitourinary studies.
On the REPROCELL blog
Latest in Drug Discovery
Breaking Ground in Alzheimer’s Research: A New Path to Drug Discovery and Personalized Medicine
22 August 2024
AI in Drug Discovery: The Role of SHAP in Pharmacology
11 July 2024
Harnessing Functional Genomics to Revolutionize Inflammatory Bowel Disease Treatment
07 June 2024
Leveraging Human Tissue Models with Preclinical and Drug Discovery CRO
05 April 2024
